|
Level of drug resistance, indicated as IC50-values (ng/ml) |
||
| Cell line |
IC50-doxorubicin |
IC50-vincristin |
|
|
||
| UKF-NB-2 |
7.4 ± 3.8 |
0.78 ± 0.23 |
| UKF-NB-2DOX |
62 ± 12 |
22 ± 7 |
| UKF-NB-2VCR |
91 ± 18 |
51 ± 12 |
| UKF-NB-3 |
8.9 ± 2.0 |
0.37 ± 0.12 |
| UKF-NB-3DOX |
63 ± 11 |
195 ± 41 |
| UKF-NB-3VCR |
91 ± 18 |
51 ± 12 |
| IMR-32 |
6.2 ± 3 |
0.73 ± 0.51 |
| IMR-32DOX |
75 ± 14 |
2.08 ± 0.34 |
| IMR-32VCR |
43 ± 11 |
20 ± 6 |
| UKF-NB-4 |
214 ± 31 |
26 ± 8 |
Blaheta et al. BMC Cancer 2006 6:294 doi:10.1186/1471-2407-6-294 |
||